Ann Khalsa, AAHIVS, MD, is the clinic medical director at Valleywise Community Health Center – McDowell. She is board certified in family medicine and credentialed as an HIV Specialist through the American Academy of HIV Medicine.
Dr. Ann Khalsa attended medical school at the University of Southern California (USC). After completing her Family Medicine residency, she joined the medical school faculty at USC, directing the HIV clinical training program for Pacific AIDS education and Training Center (AETC) from 1990-2005. She cared for HIV patients at the Los Angeles County-USC Rand Schrader HIV Clinic, LAC-USC Maternal Child Adolescent HIV Clinic, the USC Family Medicine Faculty Clinic, and the LA Gay and Lesbian Jeffrey Goodman HIV Clinic, while training hundreds of healthcare providers from the U.S. and abroad in the care of HIV disease.
Dr. Khalsa served as the Medical Director of the La Fe Ryan White clinic in El Paso Texas, where she provided full time HIV clinical care while continuing her teaching activities through the Texas-Oklahoma AETC, traveling throughout the U.S. as well as Latin America and Japan.
Since 2010, Dr. Khalsa has continued to provide full-time clinical care of HIV-infected patients at Valleywise Community Health Center – McDowell. She supervises a staff of 9 additional clinical providers who care for over 4,500 patients. The clinic is the largest Ryan White provider in the state of Arizona and conducts HIV clinical research, and also provides care to HIV-uninfected patients for hepatitis C, transgender care, and HIV prevention.
In addition, she directs the anal dysplasia (pre-cancerous condition) screening and treatment program at the clinic and continues to lecture on HIV treatment and prevention throughout the U.S. She also trains the Mayo Clinic infectious disease fellows in ambulatory HIV care as an Assistant Professor of Medicine with the Mayo Clinic College of Medicine and Science.
Dr. Khalsa, a District Medical Group (DMG) physician, is available for consultation at Valleywise Health.
American Board of Family Medicine
American Academy of HIV Medicine
Keck School of Medicine of the Univ. of S. C.
Los Angeles, CA
Arrowhead Regional Medical Center
One of the new treatments for HIV/AIDS approved by the FDA is cabotegravir and rilpivirine. Cabotegravir and rilpivirine are long-acting injectable HIV treatments. The two medications are available as a monthly injection administered by a healthcare provider.
Understanding HIV and AIDS can help you detect the disease in its early stages and begin treatment. Learn more about the virus and where you can get tested.
We talked to experts from the Valleywise Health Community Health Center – McDowell about common myths and misconceptions surrounding HIV/AIDS and how important it is to seek treatment right away.
It’s normal to be scared and overwhelmed after finding out you tested positive for HIV. Nowadays, HIV is considered a chronic treatable condition, so knowing your status is the best first step to staying healthy with medical treatment and self-care.